ACADEMIC:

• B.Pharm. Jadavpur University, Kolkata, West Bengal India- 2008
• M.Pharm. (Pharmacology)-Jadavpur University, Kolkata, West Bengal India -2010
• Ph.D. (Pharmacy). Jadavpur University, Kolkata, West Bengal India -2014

EMPLOYMENT

• Associate Professor-I; Division of Life Sciences, Institute of Advanced Study in Science and Technology (IASST), Vigyan Path, Guwahati, PIN- 781035 Assam, India (Oct 2022 onwards)
• Associate Professor; Division of Pharmacology, Guru Nanak Institute of Pharmaceutical Science and Technology (Got Autonomous Status by UGC), Kolkata, India (Nov 2019- Oct 2022).
• Faculty; Senior Lecturer, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research- Hajipur (Dept. of Pharmaceutical, Govt. of India) Bihar, India (Sep 2018 - Nov 2019).
• Post-Doctoral Research Fellow; Department of Pharmacology, University of the Free State, Bloemfontein, South Africa (Mar 2017- Aug 2018)
• Assistant Professor; Division of Pharmacology, Guru Nanak Institute of Pharmaceutical Science and Technology, Kolkata, India. (Availed Sabbatical leave for Post-Doctoral Research) (July 2013- March 2017)

AWARDS/ RECOGNITION/ACHIEVEMENT: 

• March 2023: Received "Bentham's Outstanding Reviewer Award" 2023.
• June 2022: Received “JIS SAMMAN” as Faculty with “Highest number of Publications”; Awarded by JIS Group Kolkata.
• February 2021: Received “JIS SAMMAN” as Faculty with “Best Research Credential”; Awarded by JIS Group Kolkata.
• June 2021: Doctoral Committee Member at Maulana Abul Kalam Azad University of Technology (MAKAUT), West Bengal Dept. of Biomedical Engineering.
• May 2020: Selected as Associate Editorial Board Member, Endocrine Metabolic & Autoimmune Disorders, (JCR 2021 Impact Factor 387), Published by Bentham Science Publication- Official Journal of Association of Medical Endocrinologists- Italy.
• Jan 2019- Nov 2019: Served as Academic Coordinator (Pharmacology and Toxicology); National Institute of Pharmaceutical Education and Research (NIPER), (Department of Pharmaceutical Govt. of India).
• June 2018: Received “Outstanding Contribution for Reviewer Award” from Elsevier, Journal of Ethnopharmacology (Impact Factor: 5.195).
• 2018- onwards: Selected and qualified as CPCSEA (Ministry of Fisheries, Animal Husbandry and Dairying, Govt. of India) nominee of the Institutional Animal Ethical Committee
• Jan 2018: Received the University of the Free State- Travel Grant to attend ISE- SFEC 2018, At the University of Dhaka, Dhaka Bangladesh, and January 13-15
• October 2017: Received Travel Grant to Attend India-South Africa Collaborative Meet 2017, Hotel Southern , Durban, South Africa.
• August 2017: Received “Outstanding Contribution for Reviewer Award” from Elsevier, International Journal of Biological Macromolecules (Impact Factor: 8.025).
• September 2017: Received Bursaries to attend DST-RSA Science IKS Exhibition Nelspruit, Mpumalanga South Africa, September 26-29.
• 2017 onwards: Member of the South African Society of Basic and Clinical Pharmacology.
• 2016 onwards: Life Member of the Indian Pharmacy Graduate Association. 
• 2016: Organized International Seminar at Guru Nanak Institute of Pharmaceutical Science and Technology as Organizing Secretary in collaboration with the Indian Pharmacy Graduate Association.
• 2015: Organized West Bengal State Council of Science & Technology sponsored and DST Govt. of India supported one-day “National Seminar- National Science Day” at Guru Nanak Institute of Science and Technology as Organizing Secretary. 
• December 2015: Received “Dr. A.K. Nag Chaudhury Memorial Award” From Society for Ethnopharmacology -India, in 2nd National convention organized by SNPS Jadavpur University Kolkata.
• 2014-2015: Experienced as “Officer in Charge” of the University Semester Examination of West Bengal University of Technology presently MAKAUT at GNIPST.
• 2015 - onwards: Selected as Editorial Board Member of the Journal” Advanced in Modern Oncology Research” by “PiscoMed Publishing”
• Dec 2012: Received Travel Grant” and Bursaries to attend the ISE 2012, Organized by the International Society of Ethnopharmacology, at Science City Kolkata, India
• 2011- Senior Research Fellowship (SRF) Awarded Indian Council of Medical Research (ICMR).
• 2010- Junior Research Fellowship (JRF) at Department of Pharmacology, Institute of Post Graduate Medical Education and Research (IPGME&R), Kolkata (BRNS-DAE Funded Project).
• 2008: Qualified GATE (Pharmaceutical Science)

PUBLICATIONS:

1. Sur D, Mondal C, Balaraman AK, Haldar PK, Maji HS, Bala A*. Attenuation of COX-2 enzyme by modulating H₂O₂-mediated NF-κB signaling pathway by monoamine oxidase inhibitor (MAOI): a further study on the reprofiling of MAOI in acute inflammation. Inflammopharmacology. 2023 Feb 24. doi: 10.1007/s10787-023-01165-5. Epub ahead of print. PMID: 36826724. (2021 Impact Factor: 5.093). (Corresponding author).
2. Maitra Subarnarekha, Bhattacharya Debarati, Paul Souvik, Ghosh Chowdhury Payel, Mandal Dipanjan, Haldar Pallab Kanti, Kumar Balaraman Ashok and Bala Asis*, Programmed Cell Death Protein 1 (PD-1) in relation to PANoptosis: Immune Pharmacological Targets for Management of Breast Adenocarcinoma, Endocrine, Metabolic & Immune Disorders - Drug Targets 2023; 23. https://dx.doi.org/10.2174/1871530323666230213121803. (2021 Impact Factor = 2.387). (Corresponding author).
3. Sur D, Dutta A, Mondal C, Banerjee A, Haldar PK, Maji HS, Bala A. Repurposing monoamine oxidase inhibitors (MAOI) for the treatment of rheumatoid arthritis possibly through modulating reactive oxidative stress mediated inflammatory cytokines.. Inflammopharmacology. 2022 Apr;30(2):453-463. (2021 Impact Factor: 5.093). (Corresponding author).
4. Matsabisa MG, Bala A, Tripathy S, Digashu MM, Rautenbach F, Dassarma B, Erhabor JO, Braga FC, Mukherjee PK, Tang M, Kang Y. Study on South African Indigenous Teas-Antioxidant Potential, Nutritional Content, and Hypoxia-Induced Cyclooxygenase Inhibition on U87 MG Cell Line. Molecules. 2022 May 30;27(11):3505. doi: 10.3390/molecules27113505. (2021 Impact Factor: 4.927). (Co- author).
5. Bala A, Sengupta A, Matsabisa MG, Chabalala HP COVID-19: Pathophysiology; Mechanism of Transmission and Possible Molecular Drug Target for Management.. Curr Mol Pharmacol. 2020 Aug 30. doi: 10.2174/1874467213999200831104324. (2021 Impact Factor = 3.855). (First and corresponding author).
6. Mooko T, Bala A, Tripathy S, Kumar CS, Mahadevappa CP, Chaudhary SK, Matsabisa MG Cannabis Sativa L. Flower and Bud Extracts inhibited In vitro Cholinesterases and b-Secretase Enzymes Activities: Possible Mechanisms of Cannabis use in Alzheimer Disease.. Endocr Metab Immune Disord Drug Targets. 2021 Feb 22. doi: 10.2174/1871530321666210222124349. (2021 Impact Factor = 2.387). (Co- author).
7. Bala A, Panditharadyula Role of Nuclear Factor Erythroid 2-Related Factor 2 (NRF-2) Mediated Antioxidant Response on the Synergistic Antitumor Effect of L-Arginine and 5-Fluro Uracil (5FU) in Breast Adenocarcinoma. Curr Pharm Des. 2019;25(14):1643-1652. (2021 Impact Factor = 3.31). (First and corresponding author).
8. Bala Asis, Matsabisa Possible importance of Cannabis sativa L. in regulation of insulin and IL-6R/MAO-A in cancer cell progression and migration of breast cancer patients with diabetes. SA Journal of Science 2018;114(7/8), http://dx.doi. org/10.17159/sajs.2018/a0279. (2021 Impact Factor: 2.134). (First author).
9. Bala Asis, Mondal , Haldar PK., Khandelwal B. Oxidative stress in inflammatory cells of patient with Rheumatoid Arthritis: Clinical Efficacy of Dietary Antioxidants. Inflammopharmacol. 2017. 25(6):595-607. (2021 Impact Factor: 5.093). (First and corresponding author).
10. Bala Asis, Rademan Sunelle, Ndiyhuwo Khorommbi Kevin, Maharaj Ninesh, Matsabisa Motlalepula UPLC-MS analysis of Cannabis sativa L usingtetrahydrocannabinol (THC), Cannabidiol (CBD) and tetrahydrocannabinolic acid (THCA) as marker compounds: Inhibition of breast cancer cell survival and progression. Natural Product Communications. 2019. https://doi.org/10.1177/1934578X19872907 (2021 Impact Factor: 1.496). (First author).
11. Bala Asis. Mukherjee PK. Braga FC. Matsabisa MG. Comparative inhibition of MCF-7 breast cancer cells growth, invasion and angiogenesis by Cannabis sativa sourced from sixteen different geographic locations. SA J Botany, 2018. Volume 119, November 2018, Pages 154-162. (2021 Impact Factor: 3.111). (First author).
12. Bala Asis. Chetia P, Dolai N, Khandelwal B, Haldar Cat’s whiskers flavonoid attenuated oxidative DNA damage in macrophages cells: Its Importance in patients with Rheumatoid Arthritis. Inflammopharmacol. 2014; 22(1):55-61. (2021 Impact Factor: 5.093). (First and corresponding author).
13. Kundu S., Bala Asis, Ghosh P., Mitra A., Sarkar A., Bauri , Ghosh A., Chattopadhyay S., Chatterjee M., Attenuation of oxidative stress by Allylpyrocatechol in synovial cellular infi ltrate of patients with Rheumatoid Arthritis. Free Radical Research, 2011. 45(5): 518-526. (2021 Impact Factor: 4.354). (Co- author).
14. Bala Asis, Haldar PK., Kar B., and Naskar S., and Mazumder UK., Carbon tetrachloride: A hepatotoxin causes oxidative stress in murine peritoneal macrophage and peripheral blood lymphocyte Immunopharmacol Immunotoxicol. 2012. 34:135–142. (2021 Impact Factor: 3.712). (First and corresponding author).
15. Chakraborty M, Bala Asis, Bhattacharya S, Haldar Pharmacog. Hypoglycemic effect of ethyl acetate fraction of methanol extract from Campylandra aurantiaca rhizome on high fat diet and low dose streptozotocin- induced diabetic rats. Pharmacog. Mag. 2018; 14(59): 539-545. (2021 Impact Factor: 0.948). (Co- author).
16. N Dolai, I Karmakar, RB Suresh Kumar, Bala Asis, UK Mazumder, Antitumor potential of Castanopsis indica (Roxb. ex Lindl.) A. DC. Leaf extract against Ehrlich's ascites carcinoma cell. Indian Journal of Experimental Biology. 2012. 50 (5), (2021 Impact Factor: 0.944). (Co- author).
17. Dolai N, Karmakar I, Suresh Kumar RB, Kar B, Bala Asis, Haldar PK. Evaluation of antitumor activity and in vivo antioxidant status of Anthocephalus cadamba on Ehrlich ascites carcinoma treated mice. J Ethnopharmacol. 2012; 1;142(3):865-70. (2021 Impact Factor: 5.195). (Co- author).
18. Bala Asis, Kar B., Karmakar I., Kumar RBS., Haldar PK., Antioxidant activity of Cat’s whiskers flavonoid on some reactive oxygen and nitrogen species generating inflammatory cells is mediated by scavenging of free radical, Chin J Natural Medicine. 2012. 10(5): 321-327. (2021 Impact Factor: 3.00). (First and corresponding author).
19. Naskar S, Mazumder UK, Pramanik G, Gupta M, Kumar RB, Bala Asis, Evaluation of antihyperglycemic activity of Cocos nucifera Linn. on streptozotocin induced type 2 diabetic rats. J Ethnopharmacol. 2011; 8;138(3):769-73. (2021 Impact Factor: 5.195). (Co-author).
20. Bala Asis, Kar , Haldar PK., Mazumder UK., Bera S., Evaluation of anticancer activity of Cleome gynandra on Ehrlichs' Ascites Carcinoma treated mice. Journal of Ethnopharmacol. 2010. 129: 131-134. 2011. (2021 Impact Factor: 5.195). (First and corresponding author).
21. Haldar PK., Bhattcharya S., Bala Asis, Kar B., Mazumder UK.,Dewanjee S. Chemopreventive role of Indigofera aspalathoides against 20- methylcholanthrene-induced carcinogenesis in Toxicological & Environmental Chemistry. 2010. 92: (9); 1749-1763. (2021 Impact Factor: 1.565).(Co-author).
22. PK Haldar, B Kar, Bala Asis, S Bhattacharya, UK Antitumor activity of Sansevieria roxburghiana rhizome against Ehrlich ascites carcinoma in mice. Pharmaceutical Biology. 2010. 48 (12), 1337-1343. (2021 Impact Factor: 3.889). (Co- author).
23. Das, S., Bala, A., Bhowmik, M., Ghosh, L.K. Attenuation of reactive nitrogen species by different flavonoids enriched fractions of Schima Wallichii. Asian Pacific Journal of Tropical Biomedicine. Asian Pacific Journal of Tropical Biomedicine. 2012. 2(2),S632-S636. (2021 Impact Factor: 1.514). (Co- author).
24. Kar, B., Kumar, R.B.S., Karmakar, I., Dolai N., Bala A., Mazumder, U.K., Hadar, P.K. Antioxidant and in vitro anti-inflammatory activities of Mimusops elengi leaves. Asian Pacific Journal of Tropical Biomedicine. 2012. 2(2), S976- S980. (2021 Impact Factor: 1.514). (Co- author).
25. Dolai, N., Karmakar, I., Kumar, R.B.S., (...), Bala, A., Haldar, P.K. Free radical scavenging activity of Castanopsis indica in mediating hepatoprotective activity of carbon tetrachloride intoxicated rats. Asian Pacific Journal of Tropical Biomedicine 2(1), pp. S243-S251. (2021 Impact Factor: 1.514). (Co- author).

 Book Chapter Publication     

• Isolation and HPLC characterization of the flavonoid fractions from Cleome gynandra and comparative antioxidant Bala Asis, Karmakar I., Haldar PK., In: Recent Progress in Medicinal Plants- Ethnomedicine and Theraputic validation, Edited by Dr. J.N. Govil, Studium Press USA Vol. No. 32, Ch. 10, Page 225-240. 2012. (First and corresponding author).
• Debjeet Sur, Pallab Kanti Haldar, Himangshu Sekhar Maji, Ashok Kumar Balaraman, Lopamudra Roy, Asis Bala ;Role of GSK-3 in the Regulation of Insulin Release and Glucose Metabolism, Free Radical Biology of Endocrine, Metabolic & Immune Disorders (2022) 1: 42. https://doi.org/10.2174/9789815049220122010006.
• Debanjana Das, Sumit Kumar, Asis Bala, Chaitali Mondal ;Regulatory Role of Immune Cell-mediated Antibodies in Rheumatoid Arthritis, Free Radical Biology of Endocrine, Metabolic & Immune Disorders (2022) 1: 113. https://doi.org/10.2174/9789815049220122010009.

Book Publication (Sole Editor)

Free Radical Biology of Endocrine, Metabolic and Immune Disorders; Editor Asis Bala; Bentham Publishers 2022. https://benthamscience.com/ebook_volume/3347

Patent (Published & FILED)

• Filed a Patent to Intellectual Property India -Govt. of India (Application Number: 2016310632499) The Indian Patent Office Journal 13/2018 Dated 30/03/2018 (Filed & Published). (Inventor: Dr. Asis Bala)
• Filed a Patent to Intellectual Property India -Govt. of India Hydrophobically modified water soluble derivative of chitosan as potential hemostatic agent. Filed: Docket No 8116 Intellectual Property India 2020. (As co-inventor)

• “Development of layered double hydroxide (LDH) nanoclays for topical delivery of RNAi for sustained protection of economically important plants against pest attack" Funded by DBT Govt. of India [Total 41.9 Lakh]- Co Principal Investigator.

Pharmacology and Drug Discovery Research Lab...

Will be updated soon...

1. CSIR-JRF/UGC-JRF/DST-INSPIRE Fellowship recipient candidates are encouraged to apply for Ph.D.
2. Ph.D. candidates will be selected through the selection test conducted by IASST.
3. Postgraduate/graduate students may contact for summer internship/training.
4. Postgraduate students (M.S. (PHARM)/M.Pharm./MSc/M.Tech.) may contact for dissertation work.